Cargando…

Real‐world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD

INTRODUCTION: The third‐generation subcutaneous implantable cardioverter‐defibrillator (S‐ICD) (EMBLEM™ A219, Boston Scientific) contains a new diagnostic tool to detect atrial fibrillation (AF) in S‐ICD patients, without the use of an intracardiac lead. This is the first study to evaluate the perfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baalman, Sarah W.E., Mittal, Suneet, Boersma, Lucas V.A., Perschbacher, Dave, Brisben, Amy J., Mahajan, Deepa, de Groot, Joris R., Knops, Reinoud E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Subcutaneous Icd
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754353/ https://www.ncbi.nlm.nih.gov/pubmed/32662101 http://dx.doi.org/10.1111/pace.14010

Ejemplares similares

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
por: De Veld, J A, et al.
Publicado: (2023)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients
por: Baalman, S. W. E., et al.
Publicado: (2018)

A tertiary centre experience of routine exercise testing as part of subcutaneous ICD vector mapping
por: Hall, P, et al.
Publicado: (2023)

Clinical predictors of very low defibrillation threshold in the extravascular ICD
por: Murgatroyd, F, et al.
Publicado: (2023)

Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices
por: Som, Z, et al.
Publicado: (2023)

A 25-year single-center experience with transvenous and subcutaneous ICD patients under thirty years of age
por: Lewandowski, M, et al.
Publicado: (2023)

A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation
por: Lopez Perales, C, et al.
Publicado: (2023)

ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
por: Kleemann, T, et al.
Publicado: (2023)

Noise caused by involuntary muscle response may inhibit detection of ventricular fibrillation during defibrillation testing
por: Baalman, Sarah W.E., et al.
Publicado: (2019)

Amiodarone does not significantly affect the success rate of ventricular fibrillation induction tests performed during or after ICD implantation. Insights from the German DEVICE registry
por: Wiedmann, F, et al.
Publicado: (2023)

Quality improvements anticipated by guideline adherence to peri-operative ICD deactivation
por: Finnerty, D, et al.
Publicado: (2023)

Capsulectomy: a safe and effective way to lower shock impedance in S-ICD replacement procedures
por: Wuerfel, S, et al.
Publicado: (2023)

Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
por: Gold, Michael R., et al.
Publicado: (2020)

Defibrillation testing during S-ICD implantation: How relevant? Results from a multicenter study
por: Ben Kilani, M, et al.
Publicado: (2023)

The VDD ICD lead: Friend or Foe?
por: Mittal, Suneet
Publicado: (2020)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

Do co-morbidities, frailty and functional status identify patients who may not benefit from ICD therapy?
por: Wilson, D G, et al.
Publicado: (2023)

Evaluation of MADIT II risk stratification score among registry of heart failure patients with primary prevention ICD/CRTD device
por: Rav Acha, M, et al.
Publicado: (2023)

Complications related to elective generator replacement of the subcutaneous implantable defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
por: Cabrera Borrego, E, et al.
Publicado: (2023)

Trends in adoption of extravascular devices compared to conventional devices: real-world data from the Netherlands Heart Registration
por: Breeman, K T N, et al.
Publicado: (2023)

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023)

Intermuscular two-incision technique for implantation of the subcutaneous implantable defibrillator: 3-year follow-up
por: Migliore, F, et al.
Publicado: (2023)

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
por: Knops, Reinoud E, et al.
Publicado: (2022)

Perioperative and postoperative pain in patients undergoing subcutaneous implantable cardioverter-defibrillator placement
por: Bisignani, A, et al.
Publicado: (2023)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
por: Lambiase, Pier D., et al.
Publicado: (2020)

Subcutaneous ICD for more and transvenous ICD for few?!
por: Abdin, Amr, et al.
Publicado: (2022)

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry
por: Lambiase, Pier D., et al.
Publicado: (2014)

Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design
por: Baalman, S. W. E., et al.
Publicado: (2018)

Early Experience with the Subcutaneous ICD
por: Lambiase, Pier D., et al.
Publicado: (2014)

Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator
por: Lloyd, Michael S., et al.
Publicado: (2023)

High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors’ reply
por: van der Stuijt, Willeke, et al.
Publicado: (2021)

Recent advances in the entirely subcutaneous ICD System
por: Bettin, Markus, et al.
Publicado: (2015)

Subcutaneous ICD: Current standards and future perspective
por: Kaya, Elif, et al.
Publicado: (2019)

Abdominal Emergency After Subcutaneous ICD Implantation
por: Petty, S. Allan, et al.
Publicado: (2022)

Subcutaneous ICD lead position affects defibrillation threshold
por: Sugumar, Hariharan, et al.
Publicado: (2017)

The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Karimianpour, Ahmadreza, et al.
Publicado: (2021)

Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Eckert, Henrik, et al.
Publicado: (2022)

Subcutaneous ICD implant complicated by an intraperitoneal lead course and device infection
por: Kaufmann, Michael R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9b0olh6ucnr5jjhgd998sf2645